SFRP2 and chronic obstructive pulmonary disease: However, Zhou et al. demonstrated that serum sFRP2 was significantly upregulated in patients with COPD and knockdown of sFRP2 in peripheral blood mononuclear cells (PBMCs) attenuated airway inflammation (57).